Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex

Cellular senescence is a crucial tumor suppressor mechanism. We discovered a CAPERα/TBX3 repressor complex required to prevent senescence in primary cells and mouse embryos. Critical, previously unknown roles for CAPERα in controlling cell proliferation are manifest in an obligatory interaction with TBX3 to regulate chromatin structure and repress transcription of CDKN2A-p16INK and the RB pathway. The IncRNA UCA1 is a direct target of CAPERα/TBX3 repression whose overexpression is sufficient to induce senescence. In proliferating cells, we found that hnRNPA1 binds and destabilizes CDKN2A-p16INK mRNA whereas during senescence, UCA1 sequesters hnRNPA1 and thus stabilizes CDKN2A-p16INK. Thus CAPERα/TBX3 and UCA1 constitute a coordinated, reinforcing mechanism to regulate both CDKN2A-p16INK transcription and mRNA stability. Dissociation of the CAPERα/TBX3 co-repressor during oncogenic stress activates UCA1, revealing a novel mechanism for oncogene-induced senescence. Our elucidation of CAPERα and UCA1 functions in vivo provides new insights into senescence induction, and the oncogenic and developmental properties of TBX3. DOI: http://dx.doi.org/10.7554/eLife.02805.001


Introduction
Senescence is defined as irreversible arrest of cell growth and loss of replicative capacity (Hayflick, 1965). Senescent cells have a large, flattened morphology and a characteristic secretory phenotype. They may be multinucleate, exhibit nuclear distortion, and contain senescence-associated heterochromatin foci (SAHFs) (Kosar et al., 2011). Senescence can be induced by various stimuli such as DNA damage, metabolic or oxidative stress, or expression of oncoproteins (Larsson, 2005;Kuilman et al., 2010;Coppé et al., 2011).
Mutations in human TBX3 cause a constellation of severe birth defects called ulnar-mammary syndrome (Bamshad et al., 1997). Efforts to understand the molecular biogenesis of this developmental disorder uncovered additional functions for TBX3 beyond transcriptional repression (Fan et al., 2009;Frank et al., 2013;Kumar et al., 2014) as well as critical roles in adult tissue homeostasis (Frank et al., 2012). The pleiotropic effects of TBX3 gain and loss of function suggest its molecular activities are context and cofactor dependent.
Despite the biologic importance of TBX3, few interacting proteins or target genes have been discovered, and the mechanisms underlying its regulation of cell fate, cell cycle, and carcinogenesis are obscure. We found that TBX3 associates with CAPERα (Coactivator of AP1 and Estrogen Receptor), a protein identified in a liver cirrhosis patient who developed hepatocellular carcinoma (Imai et al., 1993). CAPERα regulates hormone responsive expression and alternative splicing of minigene reporters in vitro (Jung et al., 2002;Dowhan et al., 2005) but its in vivo functions are unknown.
We show that a CAPERα/TBX3 repressor complex is required to prevent premature senescence of primary cells and regulates the activity of core senescence pathways in mouse embryos. We discovered co-regulated targets of this complex in vivo and during oncogene-induced senescence (OIS), including a novel tumor suppressor, the lncRNA UCA1. UCA1 is sufficient to induce senescence and does so in part by sequestering hnRNP A1 to specifically stabilize CDKN2A-p16 INK mRNA. Our finding that CAPERα/TBX3 regulates p16 levels by dual, reinforcing mechanisms position CAPERα/TBX3 and UCA1 upstream of multiple members of the p16/RB pathway in the regulatory hierarchy that controls cell proliferation, fate and senescence.

CAPERα interacts with TBX3 in vivo
We recently discovered that TBX3 (human) and Tbx3 (mouse) interact with RNA-binding and splicing factors (Kumar et al., 2014). Among these, mass spectrometry of anti-TBX3 immunoprecipitated eLife digest Cell division and growth are essential for survival. But it is equally important that cells can stop dividing, because failing to do so can lead to the uncontrolled tumor growth seen in cancer. One such quality control mechanism is called senescence, which stops the growth and multiplication of cells that are old, damaged or behaving in ways that may harm the organism. All cells eventually stop dividing and undergo senescence, but a number of factors may trigger the process early, such as DNA damage, stress or the appearance of cancer-causing proteins.
Senescence can be harmful if it occurs too early in life and interferes with normal growth. Severe birth defects-including fatal heart problems and limb malformations-occur if senescence is inappropriately triggered early in development. Mutations in a gene encoding a protein called TBX3 have been linked to these severe birth defects.
Normally, TBX3 stops the production of other proteins that trigger senescence in early development, and helps to maintain stable conditions in adult cells. Understanding how it does so could help scientists understand normal cell function and aging, and also help to find ways to trigger senescence in cancerous cells. Kumar et al. found that a protein called CAPERα-for short Coactivator of AP1 and Estrogen Receptor-forms a complex with TBX3 that stops cells dividing in living organisms in at least two different ways. One way is by altering how DNA is folded. The other way involves a non-coding strand of RNA from a gene called UCA1: this RNA prevents the degradation of proteins that stop cell division.
In normal proliferating cells, the CAPERα/TBX3 protein complex prevents the production of UCA1 RNA. In contrast, in cells that received a cancer causing stimulus, TBX3 and CAPERα physically separate: this activates production of UCA1 RNA and causes senescence. Further studies will be required to establish exactly how the CAPERα/TBX3 protein complex interacts with DNA and RNA to control senescence and prevent cancer.
(IP'd) proteins identified CAPERα ( Figure 1A). Since TBX3 functions in mammary development and may contribute to the pathogenesis of breast and other hormone responsive cancers (Douglas and Papaioannou, 2013), its interaction with an ERα co-activator drove further investigation.
To determine if Tbx3 and Caperα interact in vivo, we IP'd endogenous Caperα from embryonic day (e)10.5 mouse embryo lysates ( Figure 1B). Immunoblotting for Tbx3 confirmed its interaction with Caperα ( Figure 1C, lane 5) and in vitro pull down assays revealed that their interaction is direct ( Figure 1D, lane 6). Caperα is very broadly expressed during mouse embryonic development (Moon, unpublished), whereas Tbx3 expression is very tissue specific and dynamic. We thus questioned whether the endogenous proteins interact in mouse tissues relevant to malformations seen in humans with UMS. Immunohistochemistry on sectioned e10.5 embryos showed that Tbx3 and Caperα proteins are co-expressed and have distinct localization patterns in different tissues: Caperα is detected in all dorsal root ganglia nuclei ( Figure 1E), some of which contain co-localized Tbx3; in proximal limb mesenchyme, Tbx3 and Caperα co-localize in nuclei ( Figure 1F) while in some distal cells and the ectoderm, Caperα is nuclear and Tbx3 is cytoplasmic ( Figure 1G, white arrowheads). Such tissue specificity suggests that functions of the Caperα/Tbx3 complex are context dependent.
TBX3 DNA binding and repressor domains (DBD, RD) independently mediate interactions with partner proteins (Carlson et al., 2001;Coll et al., 2002;Kumar et al., 2014). To identify domains required for CAPERα interaction, we used a series of overexpression plasmids encoding mouse Tbx3 proteins with different mutations and functional domains ( Figure 1H). The DBD, deleted repressor domain (ΔRD) and exon7 missense mutants are untagged proteins, whereas the C-terminal deletion mutants are Myc-tagged.
To assay the interactions of the untagged exogenous proteins with endogenous CAPERα in HEK293 cells, we needed to knockdown endogenous TBX3 with shRNA ( Figure 1I). We previously demonstrated that mutant Tbx3 proteins produced from the overexpression plasmids are present in TBX3 knockdown HEK293 cells (Figure 2 in Kumar et al. 2014). CAPERα is present and can be IP'd in the context of knockdown of endogenous TBX3 and subsequent overexpression of mutant mouse Tbx3 proteins ( Figure 1J). Immunoblot of anti-CAPERα IP'd samples shows that the endogenous CAPERα interacts with Tbx3 DBD mutant proteins ( Figure 1J′, lanes 2 and 3 are L143P and N227D, respectively).
The Tbx3 deletion constructs encode Myc-tagged mutants that can be distinguished from endogenous TBX3, so interactions were assayed in wild-type HEK293 cells. Myc-tagged deletion mutants are IP'd by the anti-Myc antibody ( Figure 1K), and probing anti-Myc IP'd material for CAPERα reveals that deletions more proximal than amino acid 655 disrupt the CAPERα/Tbx3 interaction ( Figure 1K′).
The observation that deletions of the Tbx3 C-terminus disrupt the CAPERα/Tbx3 interaction led us to test whether the C-terminal repressor domain, which is crucial for the ability of Tbx3 to function as a transcriptional repressor and immortalize fibroblasts (Carlson et al., 2001), plays a role. Although the untagged ΔRD mutant is produced in TBX3 shRNA knockdown cells and IP'd by the anti-Tbx3 antibody ( Figure 1L and Kumar et al., 2014) it does not interact with CAPERα ( Figure 1L′). CAPERα also fails to interact with a C-terminal Tbx3 frameshift mutant similar to one identified in humans with UMS (Bamshad et al., 1999) (Figure 1-figure supplement 1).
CAPERα and TBX3 are required to prevent premature senescence of primary human and mouse cells Roles for TBX3 in cell cycle regulation and senescence of primary cells have not been reported. We employed loss-of-function to test whether TBX3 is required for sustained proliferation of primary cultured human foreskin fibroblasts (HFFs) and to determine if CAPERα functions in this process. We tested two different CAPERα and TBX3 shRNAs (please see 'Materials and methods' for sequences and location in target mRNAs). Both CAPERα and TBX3 shRNAs effectively decreased the amount of CAPERα mRNA (Figure 2-figure supplements 1A and 2A,B). Knockdown of either protein resulted in a dramatic increase in senescence associated β-galatosidase activity (SA-βgal, Figure 2A The effects of CAPERα and TBX3 KD on HFF cell growth, and SA-βgal activity suggest induction of premature senescence. Consistent with this, both KDs dramatically influenced nuclear structure, Figure 1. CAPERα and TBX3 directly interact via the TBX3 repressor domain. (A) Representative spectrum for CAPERα identified in anti-TBX3 co-IP of HEK293 cell lysates. Mass spec analysis identified six specific CAPERα peptides, providing 8.5% sequence coverage of the protein. This spectrum shows fragmentation of one of these peptides, C*PSIAAAIAAVNALHGR, with diagnostic b-and y-series ions shown in red and blue, respectively. * indicates Figure 1. Continued on next page chromatin organization and formation of SAHFs ( Figure 2G-J). Expression of senescence mediators was increased and conversely, expression of cell growth and cell cycle promoting genes was similarly decreased by CAPERα and TBX3 KD ( Figure 2K-M). Increased expression of CDKN2A-p16 INK (henceforth referred to as p16 INK ) and decreased PCNA, E2F1 and 2, CDK2, CDK4, CDC2 transcripts indicate that CAPERα/TBX3 represses the p16/RB pathway in proliferating HFFs. PMAIP1, CDKN1A-p21, and other p53 pathway members were also increased. Collectively, these data indicate that CAPERα and TBX3 are required to prevent senescence of primary HFFs and act upstream of major cell cycle and senescence regulatory pathways.
Tbx3 null murine embryonic fibroblasts undergo p16/RB-mediated premature senescence, Caperα mislocalization and nuclear disruption Tbx3 deficiency in mice causes lethal embryonic arrhythmias and limb defects however, these phenotypes are not due to increased apoptosis (Frank et al., 2012 and Emechebe and Moon, unpublished). We hypothesized that Tbx3 may prevent senescence of embryonic cells, and so examined murine embryonic fibroblasts (MEFs) from e13.5 wild type (WT) and Tbx3 null (−/−) embryos. WT MEFs undergo ∼10 passages with regular, 20 hr doubling times. In contrast, Tbx3−/− MEFs had increased SA-βgal activity and ceased proliferating after only four passages ( Figure 2N 3D-F′). These data suggest that Tbx3 is required for preservation of nuclear architecture and to tether Caperα in its normal nuclear domains in proliferating cells.
Consistent with premature senescence seen in Tbx3−/− MEFs, key pro-senescence pathways are activated after loss of Tbx3 in vivo: in protein lysates from Tbx3−/− embryos, RB was hypophosphorylated on multiple serine residues, consistent with increased p16 and decreased Cdk2 and Cdk4 protein levels relative to control ( Figure 2R). The levels of p21 and other senescence markers were increased, while numerous Cyclins and other Cdks were decreased ( Figure 2R, Figure 2-figure supplement 3G). All of these findings are consistent with a requirement for Tbx3 to prevent senescence in embryonic mice and MEFs.   Previous studies have suggested that overexpression of TBX3 permits senescence bypass by directly repressing CDKN2A-p14 ARF (p14 ARF ) to activate p53 (Brummelkamp et al., 2002), but a role for TBX3 in regulating p16 INK and the RB pathway has not been demonstrated. Thus, we expected that loss of p53 would rescue senescence resulting from TBX3 or CAPERα KD. To test this, we transduced TBX3 and CAPERα KD HFFs with shRNA to p53 (Masutomi et al., 2003) and assayed SA-βgal activity and growth. Surprisingly, although p53 shRNA effectively decreased p53 (Figure 3-figure supplement 1A), it did not rescue SA-βgal activity or growth arrest due to absence of TBX3 or CAPERα ( Figure 3B,E,G,H). In contrast, shRNA-mediated KD of either RB (Boehm et al., 2005) or p16 (Haga et al., 2007) (Figure 3-figure supplement 1B,C) rescued these phenotypes in TBX3 and CAPERα KD cells ( Figure 3C, F-H,I-N). These rescue experiments demonstrate that the p16/RB pathway mediates senescence downstream of CAPERα and TBX3 loss-of-function in primary cells.

CAPERα/TBX3 regulates chromatin status of the p16 INK promoter
Increased p16 protein and RB hypophosphorylation in Tbx3−/− embryos and p16/RB-mediated senescence after CAPERα and TBX3 KD could result from loss of direct repression of p16 INK by CAPERα/ TBX3 in proliferating cells. We screened 7 amplicons spanning ∼6 kb upstream of p16 INK by ChIP-PCR of HFF chromatin (Figure 3-figure supplement 2); 3 amplicons were bound by CAPERα and TBX3 ( Figure 3O, lanes 7, 10). Loss of either protein decreased the heterochromatic marks H3K9me3 ( Figure 3O, lanes 14, 15) and H3K27me3 (Figure 3-figure supplement 3) and increased the euchromatic mark H3K4me3 ( Figure 3O, lanes 17, 18). Notably, less CAPERα occupied p16 INK elements after TBX3 KD ( Figure 3O, lanes 11) while the amount of TBX3 bound post-CAPERα KD was comparable to control ( Figure 3O, lanes 9 vs 7). This is consistent with the abnormal localization of CAPERα seen in We examined whether CAPERα and/or TBX3 associate with promoters of other cell cycle genes that are transcriptionally dysregulated after CAPERα/TBX3 loss-of-function ( Figure 2K-M). Antibodies against TBX3 and CAPERα ChIP'd the p14 ARF initiator   (Figure 3-figure supplement 4A); whereas knockdown of either TBX3 or CAPERα results in marked changes in cell morphology and increased lacZ staining. (D) Bar graph quantitating % beta-galactosidase positive cells from four replicate plates of SA-βgal assays. * indicates p<0.001 compared to control. (E and F) 3T5 cell proliferation assay (Lessnick et al., 2002) of cumulative population doublings in HFFs transduced at passage 30 with control, TBX3 or CAPERα shRNAs. These are representative curves of duplicate experiments; each point on the curve is a measurement of cell count from a single plating followed over the course of the experiment as described in methods. (G-J) Immunohistochemical analysis of H3K9me3 immunoreactivity (red) and DAPI (blue) in HFFs after knockdown with control (G and I), TBX3 (H), or CAPERα (J) shRNAs. Individual channels are shown and the merged image is on the right. Note increased nuclear punctate staining consistent with Senescence-associated heterochromatin foci (SAHFs) in both channels and evidence of nuclear disruption (white arrowheads in red channel) after loss of either TBX3 or CAPERα. (K-M) Analysis of cell cycle and senescence marker transcript levels in HFFs transduced with control, TBX3, or CAPERα shRNAs. (K) Relative transcript levels assessed by quantitative real time-PCR (qPCR) of cDNA. Values reflect fold change in knockdown HFFs relative to control after normalization to HPRT levels. Note general pattern of expression changes are similar in TBX3 (blue) and CAPERα (red) knockdowns. Data are plotted as fold change mean ± standard deviation. * indicates p<0.05 relative to control. (L and M) Agarose gel of PCR amplicons of cDNAs reverse transcribed from TBX3 (L) or CAPERα (M) shRNA knockdown HFF RNA reveals similar decreases in cell cycle promoting genes CDK2 and 4 in TBX3 and CAPERα knockdowns and increased p21 levels. (N and O) SA-βgal assay of wild type and Tbx3 null MEFS reveals that Tbx3 is required to prevent premature senescence of primary murine embryonic fibroblasts (MEFs). (P) Quantitation of % betagalactosidase positive cells from five replicate experiments exemplified in O, P. * indicates p<0.01. (Q) 3T5 cell proliferation assay of cumulative population doublings in wild-type and Tbx3 null MEFs. These are representative curves from duplicate experiments; each point on the curve is a measurement of cell count from a single plating followed over the course of the experiment as described in 'Materials and methods'. (R) IBs to assay levels of cell cycle and senescence proteins in wild type and Tbx3 null embryo lysates. Tubulin loading control is at top left (Tub). The changes at the protein level correlate with those observed at the RNA level (K-M) and RB is hypophosphorylated on multiple serine residues consistent with increased p16 and decreased CDK activity. TBX3, CAPERα = human; Tbx3, Caperα = mouse. DOI: 10.7554/eLife.02805.005 The following figure supplements are available for figure 2:   (Masutomi et al., 2003) or RB (Boehm et al., 2005) (Prince et al., 2004;Saramaki et al., 2006;Hoogaars et al., 2008). Testing for association with known regulatory elements of CDK2, CDK4, CDKN1B was also negative (Figure 3-figure supplement 4C-E) (Baksh et al., 2002;Wang et al., 2005;Louie et al., 2010). These data indicate that in proliferating primary cells, CAPERα/TBX3 specifically and directly repress the CDKN2A locus by binding multiple regulatory sequence elements and regulating chromatin marks.
Expression of the lncRNA UCA1 is repressed by CAPERα/TBX3 and sufficient to drive senescence of primary cells To identify novel genes repressed by CAPERα/TBX3, we employed differential display to detect transcripts that increased in response to KD of TBX3 and CAPERα in HEK293 cells ( Figure  is known to regulate cell survival and tumor progression, and overexpression induces senescence downstream of RB/E2F (Torres et al., 2003;Wang et al., 2007), thus placing CAPERα/TBX3 upstream of another p16/RB effector. Little is known about the function of the lncRNA UCA1 (Wang et al., 2006(Wang et al., , 2008, so we investigated it further. We found that shRNA KD of CAPERα or TBX3 in primary HFFS recapitulated the increase in UCA1 transcripts seen in HEK293 cells ( Figure 4E-H). We then tested whether CAPERα/TBX3 directly control transcription of UCA1 by interacting with potential regulatory elements. Public ChIP data (http:// genome.ucsc.edu/) indicate that the 2 kb upstream of UCA1 may contain such elements. We assayed 3 amplicons in this region ( Figure 4I: A1, A2, A3) by ChIP-PCR of TBX3 and CAPERα: only region A3 was bound ( Figure 4J,K, lanes 18, red arrowheads).
We next determined whether increased UCA1 expression in response to KD of CAPERα or TBX3 was associated with altered chromatin structure (as seen with p16 INK , Figure 3O). UCA1/A3 is normally in a heterochromatin configuration in HFFs, with repressive marks H3K9me3 and H3K27me3 ( Figure 4L, lanes 12, 14) and little H3K4me3 ( Figure 4L, lane 18). After TBX3 KD, activating chromatin marks replaced repressive ones ( Figure 4L, lanes 13, 15 and 19) and markedly less CAPERα was bound ( Figure 4L, lane 17, red arrowhead). CAPERα KD also led to loss of repressive marks on UCA1/ A3 ( Figure 4M lanes 9, 16), although TBX3 remained bound ( Figure 4M, lane 11, red arrowhead). Combined with previous findings, we conclude that: (1) TBX3 recruits CAPERα to UCA1/A3 chromatin, (2) TBX3 alone is insufficient to repress UCA1 and, (3) the default state of UCA1 in proliferating HFFs is repression conferred by CAPERα/TBX3. assays of HFFs stably transduced with control or p16 (Haga et al., 2007) shRNAs subsequently transduced with CAPERα or TBX3 shRNAs. (M) % Quantitation of I-L from three replicate experiments. * indicates p<0.05 relative to Ctl shRNA. (N) Cell proliferation assayed by crystal violet incorporation (OD units) in HFFs treated as in I-L. * indicates p<0.01 relative to Ctl shRNA. (O) ChIP-PCR with antibodies listed at top on three regions upstream of the CDKN2A-p16 transcriptional start site (TSS); position relative to (TSS) is indicated in parentheses at left of panels. PCR of input material used for the ChIP is shown under 'Input'. The shRNA transduced is listed above each lane (HFF Tx). TBX3 knockdown decreases binding of TBX3 (lanes 8) and CAPERα (lanes 11) to all three regions. CAPERα knockdown has minimal effect on TBX3 binding (lanes 9). Knockdown of either TBX3 or CAPERα decreases the repressive chromatin mark H3K9me3 (lanes14, 15) and increases the activating chromatin mark H3K4me3 (lanes 17, 18). TBX3, CAPERα = human; Tbx3, Caperα = mouse. DOI: 10.7554/eLife.02805.009 The following figure supplements are available for figure 3:   UCA1 modulates behavior of bladder cancer cell lines (Wang et al., 2008), but there are no data on its function in primary cells; our results suggest that UCA1 may be involved in premature senescence. UCA1 transcripts are low in proliferating HFFs, but 4 days after overexpression of UCA1 ( Figure 5A), a robust SA-βgal response is evident ( Figure 5B-D). Cells constitutively expressing UCA1 ceased proliferating during selection and accumulated SAHFs ( Figure 5E,F). Cell proliferation decreased in a UCA1 dosage-sensitive manner ( Figure 5G-I), consistent with reduced levels of cell cycle promoting transcripts and increased levels of pro-senescence ones ( Figure 5J). These transcriptional changes were manifest at the protein level ( Figure 5-figure supplement 1). Premature senescence resulting from overexpression of UCA1 in HFFs reveals that this lncRNA is a novel regulator of cell proliferation and may function as a tumor suppressor in some contexts.

Loss of UCA1 delays the onset of oncogene-induced senescence
We tested the hypothesis that UCA1 is required for induction of oncogene-induced senescence (OIS) in primary cells ('RAS': HFFs transduced with constitutively active G12V RAS [Serrano et al., 1997]). There are markedly more UCA1 transcripts in RAS compared to presenescent 'PS' HFFs ( Figure 5K). Knockdown of UCA1 in RAS HFFs reduced SA-βgal activity ( Figure 5L-Q) and improved RAS cell growth: the number of Ki67 + RAS cells was increased at days 3 and 6 after UCA1 KD ( Figure 5R, P0 and P1). However, by passage 2, the number of Ki67 + cells was not statistically different in UCA1 KD cells from control, despite persistently low levels of UCA1 ( Figure 5S) and decreased levels of prosenescence transcripts ( Figure 5T). Overall, this indicates that senescence can occur in the absence of high levels of UCA1 but that timely execution of the OIS program requires UCA1.
We next investigated whether increase in UCA1 transcripts in OIS is a manifestation of loss of CAPERα/TBX3 occupancy/repression of UCA1/A3. Indeed, the repressor dissociates from UCA1/A3 in RAS HFFs and UCA1/A3 chromatin switches from heterochromatic to euchromatic marks ( Figure 5U). This is consistent with the senescence-inducing effects of CAPERα/TBX3 loss-of-function ( Figure 2) and resulting upregulation of UCA1 (Figure 4), and establishes CAPERα/TBX3 regulation of UCA1 in an independent model of senescence. UCA1 promotes senescence by sequestering hnRNP A1 to stabilize p16 INK mRNA Some lncRNAs influence transcription by recruiting chromatin modifiers to target genes (Fatica and Bozzoni, 2014). We tested whether the increased levels of prosenescence transcripts occurring in response to UCA1 ( Figure 5J) were the result activating chromatin changes however, ChIP-PCR assay for H3K9 acetylation of the p16 INK , p14 ARF , CDKN1A-p21 (and other) promoters did not reveal changes in this activating mark in response to UCA1 ( Figure 5-figure supplement 2). We thus tested whether altered mRNA stability contributed to the observed changes. HFFs were transfected with UCA1 expression or control plasmid and after 2 days, treated with Actinomycin D. Total RNA was collected at 0-4 hr post-treatment and mRNA levels assayed using RT-PCR. Remarkably, overexpression of UCA1 resulted in the stabilization of mature p16 INK , p14 ARF , E2F1, and TGFβ1 mRNAs: in the time frame examined, p16 INK , p14 ARF , and E2F1 mRNAs do not decay and their t 1/2 values are therefore denoted as 'n' (no decay). The half-life estimates shown were calculated using linear regression; those best fit lines, their equations and R values are shown in Figure 6-figure supplement 1. t 1/2 of p16 INK mRNA in control cells was 3.9 hr vs n in UCA1 overexpressing cells; p14 ARF , 2.4 vs n; E2F1, 7.2 vs n; TGFβ1, 1.9 vs 2.9. In marked contrast, MYC, CDKN1A-p21, CDKN2D and RB mRNAs decayed at rates indistinguishable from control ( Figure 6A; Figure 6-figure supplement 1). The effects of UCA1 overexpression on p16 INK mRNA stability were confirmed by Northern blot (Figure 6-figure supplement 2).
Regulation of p16 INK transcript stability is a critical mechanism for growth control (Wang et al., 2005;Chang et al., 2010;Zhang et al., 2012) and hnRNP A1 has been postulated to stabilize p16 INK mRNA (Zhu et al., 2002), but this has not been tested. To this end, we treated HFFs with siRNA to hnRNP A1 and used Actinomycin D to assess stability of p16 INK transcripts. Loss of hnRNP A1 (Figure 6-figure supplement 3) stabilized both p16 INK (t 1/2 -2.1 in control vs 12.3 after HNRNP A1 knockdown) and p14 ARF mRNAs (t 1/2 -1.5 in control vs 6.9 after hnRNP A1 knockdown) but not those of E2F1 or MYC ( Figure 6B). Half-life estimates were obtained as described for panel A and the best fit lines, their equations and R values are shown in Figure 6-figure supplement 3B. The differences in control half-lives between Figure 6A,B are likely attributable to the different treatments used: in A, control cells were transfected with pcDNA3.1 plasmid, while in B, control cells were transfected with Research article Figure 6. UCA1 stabilizes CDKN2A-p16 mRNA levels during senescence by sequestering hnRNP A1. (A) Graphs of transcript levels assayed by RT-qPCR in HFFs transfected with control (blue) or UCA1 (red) expression plasmids and treated with Actinomycin (D). Y axis shows % mRNA level relative to time zero and X axis shows time in hours assayed post treatment. The estimated half-lives (t 1/2 ) were obtained using linear regression; the best fit lines, their Figure 6. Continued on next page control siRNA. The half-life of an mRNA is cell/context specific (as evident in the differences in control half-lives in 6A vs 6B) and in general, cell cycle regulatory genes have short half-lives (Sharova et al., 2009). The t 1/2 of p16 INK mRNA we observed in HFFs transfected with either control plasmid (t 1/2 -3.9) or control siRNA (t 1/2 -2.1) is similar to that reported in HeLa cells (t 1/2 -2.9) (Chang et al., 2010). The results we obtained were also similar to those reported for MYC mRNA (Herrick and Ross, 1994;Sharova et al., 2009), CDKN1A mRNA in HT29-tsp53 cells (Melanson et al., 2011) and ES cells (Sharova et al., 2009), and E2F1 mRNA in ES cells (Sharova et al., 2009). The half-lives of Rb and TGFβ1 are mRNAs extremely variable and those we obtained in HFFs were shorter than reported in ES cells (Sharova et al., 2009).
We next used RNA-IP (RIP) to determine if hnRNP A1 binds p16 INK and p14 ARF mRNAs in proliferating cells and found that this was indeed the case ( Figure 6C, lane 6 and Figure 6-figure supplement 4). Remarkably, hnRNP A1/p16 INK binding was lost in RAS HFFs ( Figure 6C, lane 7), despite an overall increase in the number of p16 INK transcripts ( Figure 6C, lane 3). As shown previously, UCA1 RNA levels also increase with RAS ( Figure 6D, lane 3). UCA1 is bound by hnRNP A1 in PS cells ( Figure 6D, lanes 6, 7; Figure 6-figure supplement 5), but unlike p16 INK , the hnRNP A1/UCA1 interaction increases in RAS cells ( Figure 6D, lane 7). TUG1 lncRNA serves as a negative control ( Figure 6E). Protein levels for hnRNP A1 are shown in Figure 6F. The interaction between UCA1 and hnRNP A1 is specific, as UCA1 does not bind hnRNP K, C1/C2, H, U, or D ( Figure 6-figure supplement 5). Although hnRNP A1 binds MYC and p14ARF mRNAs ( Figure 6-figure supplement 4), it does not bind RB, p21 or CDK6 mRNAs under the numerous conditions tested (Figure 6-figure supplement 6).
The opposite binding properties of UCA1 and p16 INK mRNA with hnRNP A1 in PS vs RAS HFFs led us to postulate that UCA1 stabilizes p16 INK mRNA during OIS by disrupting the interaction between hnRNP A1 and p16 INK mRNA. In control transfected proliferating cells, there is robust binding of p16 INK to hnRNP A1 ( Figure 6C, lane13), but direct overexpression of UCA1 ( Figure 6D, lane 10) or that resulting from TBX3 or CAPERα KD ( Figure 6D, lanes 17, 18) disrupts the hnRNP A1/p16 INK mRNA interaction ( Figure 6C, lanes14, 23, 24, red arrowheads). These findings support the hypothesis that loss of hnRNP A1/p16 INK mRNA interaction in OIS ( Figure 6C, lane 7) is the result of increased UCA1 expression and its binding and sequestration of hnRNP A1 ( Figure 6D, lane 7). To further test this, we used shRNA to KD UCA1 in RAS HFFs ( Figure 6D, lane 27). UCA1 KD restored the interaction between   Figure 6C, lane 31) and led to lower levels of total p16 INK mRNA ( Figure 6C, lane 27), a finding consistent with the negative effects of hnRNP A1/ p16 INK interaction on stability of p16 INK transcripts. The effects of UCA1 on p16 INK mRNA stability are specific, because hnRNP A1 interactions with MYC or p14 ARF mRNAs are unaffected by UCA1 (Figure 6-figure supplement 1).
In total, these findings indicate that in proliferating cells, the very low quantity of UCA1 transcripts is insufficient to disrupt hnRNP A1/p16 INK binding, and levels of p16 INK mRNA are low due to: (1) direct repression by CAPERα/TBX3 and, (2) p16 INK mRNA instability conferred by hnRNP A1. When UCA1 levels increase during OIS, by UCA1 overexpression, or via KD of CAPERα/TBX3, UCA1 binds and sequesters hnRNP A1, preventing it from destabilizing p16 INK mRNA.
The CAPERα/TBX3 co-repressor dissociates during oncogene-induced senescence leading to activation of UCA1 and pro-senescence pathways Increased p16 protein is required for RAS-induced senescence in MEFS and some human cell types (Serrano et al., 1997), leading us to determine whether OIS affects CAPERα/TBX3 occupancy of p16 INK chromatin. CDKN2A-p16 INK genomic regulatory elements bound in PS HFFs ( Figure 4I) were not occupied by either TBX3 or CAPERα in RAS HFFs ( Figure 7A). Chromatin marks on these regions switched from heterochromatic to euchromatic ( Figure 7B, Figure 7-figure supplement 1A). This was also observed with UCA1/A3 ( Figure 5U) and DUSP4 chromatin (Figure 7-figure supplement 1B).
We investigated the possibility that altered quantity of either CAPERα or TBX3 could disrupt the stoichiometry of their interaction and cause dissociation from p16 INK and UCA1 regulatory elements in OIS. Surprisingly, both TBX3 and CAPERα protein levels were increased in RAS HFFs ( Figure 7C), but they no longer co-IP'd ( Figure 7D, red box). Immunocytochemistry of endogenous TBX3 and CAPERα in PS and RAS HFFs confirmed increased protein levels in OIS ( Figure 7F-M), and revealed dramatic changes in CAPERα localization: CAPERα immunoreactivity became concentrated in large intranuclear foci ( Figure 7L,M), as we previously observed in early passage Tbx3−/− MEFS (Figure 2-figure supplement 2D-F′). These foci are distinct from SAHFs and PML bodies ( Figure 7M and Figure 7-figure  supplement 2).
To further investigate the molecular basis of senescence initiation after loss of CAPERα/TBX3, we performed genome-wide transcriptional profiling 2 days post CAPERα, TBX3 and control KD in HFFs. More than half of the transcripts with expression altered 1.5-fold or more by CAPERα KD were similarly affected by loss of TBX3 (N = 2375 CAPERα KD, 2188 TBX3 KD; 1157 co-regulated, p<<<<0.0001, Figure 7-source data 1-3, Figure 7N,O). Gene ontology-biologic process (GO-BP) analysis with DAVID (Huang da et al., 2009a(Huang da et al., , 2009b showed highly significant co-regulation of 'transcription regulation' (increased expression) and 'cell-cycle' (decreased expression) transcripts ( Figure 7N,O). We tested a subset of these with known roles in senescence by qPCR: 100% validated and were similarly altered by RAS (Figure 7-figure supplement 3). Further interrogation of this group revealed that IL6 and HDAC9 are CAPERα/TBX3 direct targets and their upregulation in RAS is associated with loss of CAPERα/TBX3 binding (Figure 7-figure supplement 4).
We compared CAPERα/TBX3 co-regulated transcripts to a published data set comparing PS and G12V RAS fibroblasts (Loayza-Puch et al., 2013). This revealed that 11% of CAPERα/TBX3 up-regulated transcripts were also increased by RAS ( Figure 7N′); among these, GO-BP 'programmed cell death' (31%) and 'transcription regulation' (34%) were highly overrepresented. 30% of CAPERα/TBX3 downregulated transcripts were also in the RAS data set; >1/3 of these were cell cycle genes ( Figure 7O′). In all comparisons, the number of transcripts common to both groups was greater than predicted by chance and highly statistically significant (Figure 7-source data 3). KEGG pathway analyses revealed overrepresented pathways that were common to both CAPERα/TBX3 and RAS data sets ( Figure 7N-O′, pie charts), but notably fewer pathways were shared in the upregulated group: JAK/STAT, TLR and TGFβ signaling pathways were only significantly overrepresented in the CAPERα/TBX3 data set.

Discussion
Our knowledge of the regulatory mechanisms that govern the onset and maintenance of senescence in different contexts must be considered fragmentary (Wang and Chang, 2011;Fatica and Bozzoni, 2014). In this study, we provide compelling evidence for critical and novel functions of CAPERα, the lncRNA UCA1 and TBX3 in the regulation of cell proliferation and senescence. We have discovered a CAPERα/TBX3 complex that is required to prevent senescence of primary human and mouse cells in  Figure 7P). Overexpression of UCA1 occurs after loss of TBX3/CAPERα and in OIS ( Figure 7Q), and is itself sufficient to induce senescence at least in part, by disrupting the interaction of p16 INK mRNA with hnRNP A1 leading to increased p16 INK mRNA stability ( Figure 7P,Q). Disrupting the CAPERα/TBX3 complex by decreasing the amount of either TBX3 or CAPERα, or by CAPERα mislocalization during OIS, coordinately increases activity of multiple prosenescence targets at both the transcriptional and post-transcriptional levels in a reinforcing mechanism.
Increased CAPERα has been reported in human breast cancers and a shift from cytoplasmic to nuclear localization correlates with transition from pre-malignant to malignant lesions (Mercier et al., 2009). In contrast, CAPERα co-activates vRel mediated transcription but inhibits vREL transforming activity in vitro (Dutta et al., 2008). It is likely that anti-or pro-oncogenic activity of CAPERα is determined by cell type and the interacting protein(s) present in a given context; our results suggest that CAPERα has oncogenic potential in primary cells since loss of CAPERα/TBX3 induces premature senescence, a vital tumor suppressor mechanism. CAPERα binds to regulatory chromatin domains via TBX3 but dissociates from these domains and becomes concentrated in large intranuclear foci prior to senescence induced by loss of TBX3 or during OIS. Future efforts will define the composition of CAPER + nuclear foci and the role of this nuclear subdomain during senescence induction.
The TBX3 RD is required for TBX3 to interact with CAPERα (this study), immortalize primary fibroblasts and confer senescence bypass (Carlson et al., 2001). Since loss of CAPERα activates target gene transcription despite continued TBX3 occupancy, it is the CAPERα/TBX3 complex (interacting via marks. Evaluation of chromatin marks on the other CDKN2A-p16 CAPERα/TBX3-responsive regulatory elements is shown in Figure 7- Figure 7-source data 3 for hypergeometric test, as implemented in the R statistical language, used to test significance of the number of genes found to be co-regulated between samples. (N) Venn diagrams show highly significant number of CAPERα/TBX3 co-upregulated transcripts (446 total), especially in the GO biologic process (BP) category of transcriptional regulation (122 transcripts) as assayed with DAVID. Pie chart shows KEGG pathway analysis of co-regulated genes. (N′) Venn diagram showing 48 CAPERα/TBX3 co-upregulated transcripts also upregulated by RAS/OIS (Loayza-Puch et al., 2013), especially in BP categories of transcriptional regulation and programmed cell (pc) death. qPCR validation of coregulated genes is in S. Figure 6A. Pie chart shows KEGG pathway analysis of OIS dataset. (O and O′) As in N and N′ but for downregulated genes. Pie chart in O′ shows KEGG pathway analysis of OIS data set; note most pathways are the same as in TBX3/CAPERα. (P and Q) Models of CAPERα/TBX3 repressor and UCA1 function in proliferating (PS) HFFs vs RAS HFFs. In PS cell nuclei, CAPERα/TBX3 represses UCA1, p16, p14, and DUSP4 promoters in heterochromatin which permits ongoing cell proliferation. RAS disrupts the CAPERα/TBX3 complex and CAPERα relocates to dense intranuclear foci. Pro-senescence genes including UCA1 and p16 are converted to euchromatin and their expression/products induce senescence. In the cytoplasm of PS cells, hnRNP A1 binds and destabilizes p16 mRNA, but activation of UCA1 expression in OIS allows UCA1 to sequester hnRNP A1 and stabilize p16 mRNA. TBX3, CAPERα = human; Tbx3, Caperα = mouse. DOI: 10.7554/eLife.02805.026 The following source data and figure supplements are available for figure 7: Source data 1. Differentially expressed genes after knockdown of CAPERα in HFFs detected by RNA-Seq. DOI: 10.7554/eLife.02805.027 Source data 2. Differentially expressed genes after knockdown of TBX3 in HFFs detected by RNA-Seq. DOI: 10.7554/eLife.02805.028 Source data 3. Determining the statistical significance of shared differentially expressed genes using the hypergeometric test, as implemented in the R statistical language (phyper). DOI: 10.7554/eLife.02805.029  TBX3 RD) that represses pro-senescence target loci. It will be important to determine if previously identified targets of TBX3 transcriptional repression are actually regulated by this complex.
Additional studies are warranted to determine the precise mechanisms whereby histone status is regulated by CAPERα/TBX3: TBX3 is known to interact directly with HDACs (Yarosh et al., 2008), but there are no reports of it or CAPERα interacting with histone methyltransferases or demethylases. Our recently published Mass Spec screen for Tbx3/TBX3 interactors did not identify such factors however, the screen cannot be considered exhaustive as we did not reproducibly detect HDACs or transcription factors previously reported to interact with Tbx3. Future studies to specifically determine whether TBX3 and/or CAPERα interact with, recruit, or modify the function of EZH2, SUV39 and other methyltransferases will be informative.
Previous studies showed that TBX3 represses transcription of p14 ARF (upstream of p53) (Bamshad et al., 1997;Fan et al., 2009;Kumar et al., 2014), yet embryonic lethality and mammary phenotypes of Tbx3 mutants are p53-independent (Jerome-Majewska et al., 2005). Our findings reconcile these observations because CAPERα/TBX3 represses p16 INK , the p16/RB pathway is activated in Tbx3−/− embryos, and knockdown of either RB or p16 (but not p53) prevents senescence after loss of CAPERα/ TBX3. Furthermore, Tbx3−/− and Cdk2−/−;Cdk4−/− mutant embryos share multiple phenotypes including RB hypo-phosphorylation, reduced E2F-target gene expression, decreased proliferation and premature senescence of MEFs (Berthet et al., 2012;Frank et al., 2012Frank et al., , 2013. Our discoveries of multiple CAPERα/TBX3 binding sites across the CDKN2A locus, and altered chromatin marks after TBX3 and CAPERα KD, indicate that the complex directly represses transcription by regulating chromatin structure. In total, the data conclusively demonstrate that p16 elevation, CDK2 and CDK4 downregulation, and RB hypophosphorylation mediate senescence downstream of CAPERα/TBX3 loss of function in primary human cells and Tbx3 null mutant embryos. When combined with the pleiotropic effects of CAPERα/TBX3 on UCA1, DUSP4, IL6, HDAC9 and other pathways, it is clear why loss of this repressor induces senescence. TBX3 may function in nuclear organization and structure: severe changes in nuclear morphology and mislocalization of both CAPERα and laminβ1 are apparent in Tbx3−/− MEFs after just one passage, prior to other signs of senescence. Progeria is a rare disease in which LMNA mutations induce cellular and organismal senescence in part by altering stoichiometry and interactions of type A and B Lamins. Progeria fibroblasts have decreased expression of TBX3, TBX3 interacting proteins, and TBX3 targets (Csoka et al., 2004). LMNβ1 is a TBX3 interacting protein (Kumar et al., 2014) and expression of LMNA, LMNβ1, and LMNβ2 is disrupted by TBX3/CAPERα KD (Figure 7-source data 1-3 and Figure 7-figure supplement 3). TBX3 may regulate LMN gene expression and physically interact with Lamins to influence nuclear homeostasis.
There are many downregulated genes common to the senescence responses triggered by RAS G12V and loss of CAPERα/TBX3 however, upregulated transcripts and pathways are largely distinct ( Figure 7N′). This is likely attributable to the presence of direct targets of CAPERα/TBX3 repression in the upregulated data set. It will be informative to determine which Jak-STAT, TLR, and TGFβ pathway members ( Figure 7N) are direct CAPERα/TBX3 targets, as the complex roles of these pathways in the senescence associated secretory phenotype, inducing or enforcing autocrine and paracrine senescence, and tumor progression are emerging (Hubackova et al., 2010;Senturk et al., 2010;Hubackova et al., 2012;Davalos et al., 2013).
Recent discoveries of the pervasive functions of lncRNAs as 'signals, decoys, guides and scaffolds' (Wang and Chang, 2011), conferred by their ability to interact with other nucleic acids and as protein ligands, has added new layers of complexity to regulation of transcriptional and post-transcriptional gene expression and translation. Although there has been a logarithmic increase in studies exploring lncRNA expression and activity, potential senescence-regulating activities are still largely unexplored. LncRNA HOTAIR functions as a scaffold to regulate ubiquitination of Ataxin-1 and Snurportin-1 to prevent premature senescence . Global alterations in lncRNA expression have been reported in association with replicative senescence , and telomere-specific lncRNAs that regulate telomere function during this process have been identified (Yu et al., 2014). As this manuscript was in revision, regulation of H4K20 trimethylation of rRNA genes by interaction of quiescence-induced lncRNAs PAPAS and Suv4-20h2 was reported (Bierhoff et al., 2014). To our knowledge, UCA1 is the first lncRNA sufficient to induce senescence.
UCA1 is expressed in bladder transitional cell carcinomas (Wang et al., 2006) and influences tumorigenic potential of bladder cancer cell lines (Wang et al., 2008;Yang et al., 2012). A very recent study identified hnRNP I as a UCA1 interacting protein that stabilizes UCA1 RNA; this interaction was postulated to decrease translation of p27 to support growth of the MCF7 breast cancer line (Huang et al., 2014). In contrast, our results support a tumor suppressor/prosenescence function for UCA1 in primary cells. UCA1 increases stability of p16 INK mRNA by sequestering hnRNP A1, employing a decoy mechanism that is in some aspects reminiscent of lncRNA PANDA sequestering NF-YA transcription factor to prevent activation of proapoptotic p53 targets and promote cell cycle arrest in the DNA damage response (Wang and Chang, 2011). In the case of UCA1 and hnRNP A1 however, the sequestration has a very specific effect: even though UCA1 expression stabilizes (and hnRNP A1 destabilizes) both p16 INK and p14 ARF mRNAs ( Figure 6A,B), UCA1 only disrupts the association of hnRNP A1 with p16 INK mRNA ( Figure 6C and Figure 6-figure supplement 4). In proliferating cells, abundant hnRNP A1 binds with p16 INK mRNA resulting in p16 INK degradation. In senescing cells, p16 INK mRNA levels increase via reinforcing mechanisms of increased transcription and stability: loss of CAPERα/TBX3 activates transcription of p16 INK and UCA1, in turn, UCA1 sequesters hnRNPA1.
We recognize that the systems we employed (primary HFFs, mouse embryos and MEFs), while very informative models, provide limited information directly applicable to aging or tumorigenesis without further experimentation. Our data support an important role for CAPERα/TBX3 in regulation of senescence in developmental contexts and, since the CAPERα/TBX3 complex regulates known critical tumor suppressors and there is an increasing literature supporting roles for both TBX3 and CAPERα in tumor biology, this is another worthy area for future investigation. As noted above, expression of CDKN2A-p14 ARF and CDKN1A-p21 CIP are repressed by TBX2 and TBX3 and this is postulated to confer the ability of overexpressed TBX2 and TBX3 to permit senescence bypass of Bmi1−/− and SV40 transformed mouse embryonic fibroblasts, respectively (Jacobs et al., 2000;Brummelkamp et al., 2002;Prince et al., 2004). Numerous overexpression studies have suggested a role for TBX3 in breast cancer ( (Liu et al., 2011) and references therein) and recent papers have reported the tumorigenic and proinvasive effects of overexpressed TBX3 in melanoma cells (Peres et al., 2010;Peres and Prince, 2013) which may derive in part from TBX3 repression of E-cadherin expression . More relevant to our work on the importance of the CAPERα/TBX3 complex to prevent senescence and regulate cell proliferation are reports that Tbx3 improves the pluripotency of iPS cells (Han et al., 2010) and prevents differentiation of mouse ES cells (Ivanova et al., 2006).
In conclusion, CAPERα/TBX3 acts as a master regulator of cell growth and fate, exerting pleotropic effects by at least two modes of action: (1) regulating chromatin structure and transcription of both coding and non-coding genes and, (2) modulating mRNA stability by altering the association of RNA binding proteins with target transcripts via UCA1. Further exploration will identify tissue-specific UCA1 targets and binding proteins, and determine whether the ability of TBX3 to confer senescence bypass in other contexts requires CAPERα interaction and/or UCA1 repression. Mining the pathways regulated by UCA1 and CAPERα/TBX3 will reveal factors that control cell proliferation and fate during development and disease and thus constitute novel cancer therapeutic targets.

Mass spectroscopy
Mass spectroscopy as in Kumar et al., (2014) Protein extraction and immunoprecipitation Dignam lysates were prepared and incubated for 4 hr at 4°C with the appropriate antibody followed by 2 hr at 4°C with the pre equilibrated Dynabeads Protein G (Invitrogen). Immune complexes were collected and washed three times with lysis buffer. Pelleted beads were resuspended in 6X Laemmli buffer and subjected to SDS-PAGE analysis followed by immunoblotting with specific antibodies.
Input lanes contain 5% of protein lysate used for IP; the rest was used in the IP and of the IP'd material, 25% was loaded onto the gel for immunoblotting.

MBP pull down assay
Amylose bound MBP and MBP-tagged TBX3 affinity columns were prepared as per the procedure (E8022S, NEB) described in the manufacturer's protocol. These beads were incubated with 5 and 10 μg of GST and GST-CAPER at 4°C for 8 hr. Bound proteins were eluted with reduced glutathione and analyzed by Western blotting with anti-CAPER antibody.

Cell transfection
Transfections were performed in HEK293 or EBNA-293 cells with Lipofectamine 2000 (Invitrogen) or in Human fibroblasts with X-tremeGENE HP DNA transfection Reagent (Roche) as per the manufacturer's recommendations.

Plasmids
Wild-type Tbx3 and exon 7 missense, deleted repressor domain (Tbx3ΔRD1), and Tbx3ΔNLS were generated by PCR amplification and cloned into pcDNA3.1. C-terminal deletion constructs Tbx3 1-655, Tbx3 1-623, Tbx3 1-565, Tbx3 1-470 were generated by PCR amplification and cloned into pCS2 with an N-terminal Myc tag. Tbx3 L143P and N277D point mutants were kind gifts of Phil Barnett. UCA1 and CAPERα cDNAs were cloned into pCDN3.1 and PQCXIH for over-expression studies, respectively. Sequence of all plasmids was confirmed. Tbx3 L143P and N277D point mutants plasmids were kind gifts of Phil Barnett. Wild-type CAPERα was generated by PCR amplification and then cloned into pQCXIH retroviral vector; sequence was confirmed. Full length UCA1 was amplified by PCR and then cloned into pcDNA3.1 vector; sequence was confirmed. UCA1 Cloning FP: AGTTGCGGCCGCTGACATTCTTCTGGACAATGAG UCA1 Cloning RP: TCCTGCGGCCGCTTGGCATATTAGCTTTAATGTAG CAPERα Cloning FP: CATCGCGGCCGCATGGCAGACGATATTGATATTG CAPERα Cloning RP: ACGTGGATCCTCATCGTCTACTTGGAACCAGTAG Immunofluroscence E10.5 embryos were harvested in PBS followed by overnight fixation at 4°C in 4% paraformaldehyde and processed for 7 μm cryosections. For cell lines, human fibroblasts were cultured on 8-well chamber slides (BD Flacon) and processed for Immunohistochemistry. Immunohistochemistry was performed using primary antibodies listed above and detected using donkey anti-goat or anti-rabbit Alexa fluor 594 (1:500) and goat anti-mouse Alexa fluor 488(1:500) from Invitrogen. Nuclei were stained with Hoechst or DAPI. Slides were imaged with a Nikon ARI inverted confocal microscope at the University of Utah Imaging Core.

Retroviral transduction and selection of stable cells
shRNA oligonucleotides (see sequences below) were annealed and cloned into the pGFP-B-RS, pRFP-C-RS (Origen) vector and PMK0.1 vector. shRNA against luciferase served as a negative control. Hightiter retrovirus was produced by transfection of shRNA retroviral construct along with gag/pol and VSVG encoding plasmids into EBNA-293 cells by lipofectamine 2000 reagent as per the manufacturer's protocol. Virus containing supernatant was collected after 48 hr of transfection and filtered through 0.45-μM filters (Fisher 09-720-4). HEK293 or HFFs were incubated with DMEM containing polybrene (8 mM) and 500 μl of TBX3 or CAPERα shRNA encoding retrovirus. 24 hr post infection, cells were split to lower densities and blasticidin or puromycin antibiotic selection applied for 2 days. Stably integrated colonies were selected and analyzed for knock down efficiency by western analysis using Tbx3 or CAPERα antibody. Efficacy and specificity of the pRb, p53, and p16 shRNAs was validated with second shRNAs, and these reagents have been used extensively by many investigators in the years since their initial publication (Masutomi et al., 2003;Stewart et al., 2003;Boehm et al., 2005;Haga et al., 2007;Hong et al., 2009;Elzi et al., 2012).
UCA1 shRNA: targets UCA1 exon 3 UCA1 shA FP: GATCCGTTAATCCAGGAGACAAAGAtcaagagTCTTTGTCTCCTGGATTAACTTTTTTGGA UCA1 shA RP: AGCTTCCAAAAAAGTTAATCCAGGAGACAAAGActcttgaTCTTTGTCTCCTGGATTAACG Senescence associated β-galactosidase assay Performed as per the manufacturer's protocol (9860, Cell Signaling). Population doubling assay/3T5 growth curves ( Figure 2E,F,R) Primary HFFs were plated in a 10-cm dish and transduced with retrovirus. After 24 hr, cells were cultured with antibiotic selection (puromycin or blasticidin) for an additional 24-72 hr. On day 0 of the 3T5 growth curve, cells were trypsinized, counted and 500,000 cells were then plated per 10-cm dish. This procedure was repeated every 3 days for 15 days. Population doublings were calculated by (logN1/log2) − (logN0/log2) N1 = current cell count, N0 = Initial cell count. Curves shown in Figure 2 are representative of two independent experiments.
Cell count ( Figure 5C) Primary HFFs were plated in 6-well dishes and transfected at 70% confluence. At days noted in the figure, cells were trypsinized and counted using a hemocytometer.
Crystal violet assay/optical density method of cell quantitation Senescence marker gene expression in TBX3 and CAPERα KD fibroblasts Primary HFFs were incubated with TBX3 or CAPERα or Control shRNA encoding retrovirus medium with fresh virus added every 8 hr for 48 hr, followed by antibiotic selection for 6 days. 6 days after selection, floating cells were discarded and adherent cells were utilized for senescence associated β-gal assay or preparation of RNA.

MEF isolation from WT and Tbx3 null embryos
All steps were performed under aseptic conditions. Pregnant female mice were euthanized and 13.5-day-old embryos were isolated from the uterus. Embryos were washed in sterile PBS in 60-mm tissue culture dish at room temperature and transferred into 15-ml sterile falcon tube containing 1 ml of 50% trypsin in DMEM medium. Embryos were minced using fine scissors followed by gentle pipetting with 1 ml pipette tips and dispersed into cell suspensions in 5 min. Suspensions were plated into 10-cm plates in 10 ml of DMEM with 5% FBS and penicillin/streptomycin and incubated for 8 hr in CO 2 incubator. Culture medium was replaced with fresh medium every day for 3 days. Passage 0 refers to the stage when cell suspension from the embryos was put into cell culture and subsequent passages are numbered.
Oncogene-induced senescence with constituitively active RAS V12G RAS virus was produced with pBABE-V12G RAS as per the procedure described above. HFFs were transduced with RAS virus and incubated with antibiotic selection medium (puromycin 2 μg/ml) for 4-5 days.

RNA immunoprecipitation (RIP) and RIP-PCR
For RNA immunoprecipitation, 10 million cells were lysed in 1 ml of NP-40 lysis buffer (50 mM Tris HCl, ph7.4, 150 mM NaCl, 1% NP-40 and Protease inhibitor cocktail). Lysate was cleared by centrifugation at 12,000 RCF for 15 min. Cleared lysate was immunoprecipitated independently with 5 μg of anti-hnRNP A1, anti-hnRNP D, Anti-hnRNP A2/B1, Anti-hnRNP C1/C2, Anti-hnRNP K, mIgG and R-IgG antibodies. Immune complexes were incubated with 30 μl of pre-equilibrated Dynabeads for 4 hr at 4°C. Dynabead purified immune complexes were subjected to Proteinase K digestion at 37°C for 1 hr followed by NucleoSpin RNA II purification kit and cDNA was prepared by RNA-to-cDNA EcoDry Premix kit (Clontech). cDNA was used as a template in PCR amplifications with gene specific primers. mRNA stability assays TBX3, CAPERα, or Control shRNA KD, PS and RAS HFFs were cultured in 6-well culture dishes for 2 days to 80% confluence. Then Actinomycin D was added to a final concentration of 5 mg/ml to suppress transcription. At 0, 1, 2, and 4 hr after addition of Actinomycin D, equal numbers of cells were harvested from each sample and mRNA was prepared by nucleoSpin RNA II purification kit and cDNA was prepared by RNA-to-cDNA EcoDry Premix kit (Clontech) followed by qRT-PCR for specific transcripts.

P16 INK mRNA northern blot
HFFs were transfected with pcDNA3.1 control or UCA1 expression plasmids as described above, incubated +/− Actinomycin D, and total cellular RNA was harvested at 0, 1, 2, and 4 hr post treatment. For